Completed NA INTERVENTIONAL 2-arm NCT04170972

The Role of TBC1D4 in Exercise- and Insulin-induced Glucose Metabolism in Human Skeletal Muscle

Sponsor: University of Copenhagen

Conditions Exercise Insulin Sensitivity Skeletal Muscle

Updated 7 times since 2019 Last updated: Jan 5, 2022 Started: Oct 17, 2017 Primary completion: May 1, 2019 Completion: Sep 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Exercise and Insulin Sensitivity and is currently completed. University of Copenhagen leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2022 — Jul 2024 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed
May 2021 — Feb 2022 [monthly]

Enrolling By Invitation NA

▶ Show 2 earlier versions

Jan 2021 — May 2021 [monthly]

Enrolling By Invitation NA
Dec 2019 — Jan 2021 [monthly]

Enrolling By Invitation NA

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Copenhagen

Data source: University of Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark